RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation

Abstract

These results illustrate the importance of RNF43, along with BRAF mutation in the serrated neoplasia pathway (both the sporadic and familial forms), inform genetic diagnosis protocol and raise therapeutic opportunities through Wnt inhibition in different stages of evolution of serrated polyps.